EW vs SPGI · P/E 47, rev $1.39B vs P/E 27, rev $15.34B
Edwards Lifesciences Corp (EW) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
EW currently screens at market cap $49.91B and trailing P/E 46.9. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the EW and SPGI stock pages for the full models.
Not investment advice.